ACTSI
Atlanta Clinical & Translational Science Institute
Emory Morehouse School of MedicineGeorgia Tech

Funded by: NIH | NCRR | CTSA

Rotating Image

Experimental Drug Seen to Clear Lung Cancer in Just Weeks

More people die from lung cancer than breast, prostate and colon cancer combined. It will kill nearly 160,000 people this year alone, but doctors are testing out a new experimental treatment that is making a dramatic difference.  Researchers are testing an experimental drug called Crizotinib. that targets a specific tumor cell abnormality. Dr. Suresh S. Ramalingam, of the Emory University Winship Cancer Institute and an ACTSI investigator, said, ”So the cancer cells for them to grow and multiply and spread to other parts of the body constantly require certain signals to be on, and this drug turns off the switch." Read more...